NuSynth raises ₹36.5 Cr to accelerate AI-driven chemical R&D

A startup based in Mysuru has reportedly raised ₹36.5 Cr ($4 Mn) in a seed round co-led by Avaana Capital and Shastra VC to explore AI applications in chemical synthesis. The funding, first reported by Inc42, is positioned to target the redesign and optimization of chemical R&D processes, which traditionally involve lengthy development cycles.

The company’s approach is said to involve AI-driven screening of reaction pathways, a process that has historically relied on manual experimentation. Specialty chemicals, where small-scale production and high margins prevail, may offer strong incentives for efficiency gains through such technologies. Some investors suggest that AI could reduce R&D costs in these segments, though specific metrics or adoption details remain undisclosed.

The round reflects a broader trend of AI-driven chemistry startups globally, though this startup’s focus appears to be on process optimization rather than drug discovery. Earlier coverage by StartupReader on 13 October highlighted the size of the seed round for an Indian deeptech startup. The capital is expected to support expansion of AI infrastructure and hiring, potentially positioning the company to compete with larger players in Europe and the U.S.

Investors may be watching whether such technologies can translate AI-generated pathways into commercially viable production processes. A pilot with a major chemical manufacturer could serve as a key milestone to validate scalability beyond lab-scale experiments.

Sources: analyticsindiamag.com